Skip to main navigation Skip to search Skip to main content

Worse airflow obstruction but not type 2 biomarkers identifies super-responders to tezepelumab in real-life

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)732-734
Number of pages2
JournalAnnals of Allergy, Asthma and Immunology
Volume134
Issue number6
Early online date24 Mar 2025
DOIs
Publication statusPublished - Jun 2025

Keywords

  • Asthma
  • super-responder
  • tezepelumab
  • spirometry

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pulmonary and Respiratory Medicine

Cite this